Sarepta Therapeutics (SRPT) EPS (Basic) Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -100.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 61.11% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3,856.63% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.78% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,207.14% |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 168.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 168.48% |
| Dec 31, 2025 | -338.18% |
| Sep 30, 2025 | -242.86% |
| Jun 30, 2025 | 2,771.43% |
| Mar 31, 2025 | -1,310.53% |
| Dec 31, 2024 | 117.11% |
| Sep 30, 2024 | 176.09% |
| Jun 30, 2024 | 125.93% |
| Mar 31, 2024 | 106.48% |
| Dec 31, 2023 | 161.29% |
| Sep 30, 2023 | 84.35% |
| Jun 30, 2023 | 89.81% |
| Mar 31, 2023 | -388.32% |
| Dec 31, 2022 | 13.29% |
| Sep 30, 2022 | -390.00% |
| Jun 30, 2022 | -159.80% |
| Mar 31, 2022 | 42.86% |
| Dec 31, 2021 | 40.42% |
| Sep 30, 2021 | 76.00% |
| Jun 30, 2021 | 47.15% |
| Mar 31, 2021 | -813.04% |
| Dec 31, 2020 | 24.05% |
| Sep 30, 2020 | -47.06% |
| Jun 30, 2020 | 48.40% |
| Mar 31, 2020 | 78.50% |
| Dec 31, 2019 | -54.15% |
| Sep 30, 2019 | -47.83% |
| Jun 30, 2019 | -123.95% |
| Mar 31, 2019 | -94.55% |
| Dec 31, 2018 | -454.05% |
| Sep 30, 2018 | -47.44% |
| Jun 30, 2018 | -45.22% |
| Mar 31, 2018 | -135.95% |
| Dec 31, 2017 | 77.16% |
| Sep 30, 2017 | 33.90% |
| Jun 30, 2017 | 14.81% |
| Mar 31, 2017 | 216.79% |
| Dec 31, 2016 | -12.50% |
| Sep 30, 2016 | 5.60% |
| Jun 30, 2016 | -33.66% |
| Mar 31, 2016 | 12.08% |
| Dec 31, 2015 | -33.33% |
| Sep 30, 2015 | -76.06% |
| Jun 30, 2015 | -18.82% |
| Mar 31, 2015 | -98.67% |
| Dec 31, 2014 | -369.57% |
| Sep 30, 2014 | 42.74% |
| Jun 30, 2014 | -41.67% |
| Mar 31, 2014 | 43.18% |
| Dec 31, 2013 | 90.25% |
| Sep 30, 2013 | 42.86% |
| Jun 30, 2013 | -266.67% |
| Mar 31, 2013 | -69.23% |
| Dec 31, 2012 | -3,833.33% |
| Sep 30, 2012 | -1,105.56% |
| Jun 30, 2012 | 500.00% |
| Mar 31, 2012 | -880.00% |
| Dec 31, 2011 | 96.05% |
| Sep 30, 2011 | -157.14% |
| Jun 30, 2011 | 140.00% |